Recent Updates
Recently added Catalysts
NMTC Positive Sentiment Score: 75/100

NeuroOne to Present at the H.C. Wainwright 25th Annual Global Investment Conference

Wednesday, September 6, 2023 2 min read
Key Takeaway: NeuroOne Medical Technologies Corporation announced its participation in the H.C. Wainwright 25th Annual Global Investment Conference, set to take place from September 11-13, 2023. The company will provide a pre-recorded presentation by CFO Ron McClurg, accessible to registered investors starting September 11. NeuroOne specializes in minimally invasive solutions for various neurological disorders, which may lead to improved outcomes for patients and reduced procedural costs.

Market Sentiment Analysis

POSITIVE FACTORS

  • NeuroOne is participating in a prominent investment conference, increasing its visibility.
  • The company's focus on improving surgical care for neurological disorders is highly relevant.
  • Pursuing innovative applications indicates potential for growth and advancements in their field.

Full Press Release Details

EDEN PRAIRIE, Minn., Sept. 06, 2023 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announced its upcoming virtual presentation at the H.C. Wainwright 25th Annual Global Investment Conference being held September 11-13, 2023.
A pre-recorded presentation by CFO Ron McClurg will be made available on demand to registered investors beginning Monday, September 11, 2023 at 7:00 a.m. ET.
To register for the conference, please visit the conference website. One-on-one meeting requests are available upon registration.
NeuroOne Medical Technologies Corporation is a developmental stage company committed to providing minimally invasive and hi-definition solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, chronic pain due to failed back surgeries and other related neurological disorders that may improve patient outcomes and reduce procedural costs. The Company may also pursue applications for other areas such as depression, mood disorders, pain, incontinence, high blood pressure, and artificial intelligence. For more information, visit nmtc1.com.
Caution: Federal law restricts this device to sale by or on the order of a physician.

Tags

NeuroOne Medical Technologies
Global Investment Conference

Frequently Asked Questions

When is NeuroOne's presentation at the conference?

NeuroOne's virtual presentation will be available on September 11, 2023, at 7:00 a.m. ET.

Who will present the pre-recorded session?

CFO Ron McClurg will deliver the pre-recorded presentation.

What technologies does NeuroOne focus on?

NeuroOne focuses on minimally invasive solutions for EEG recording, brain stimulation, and ablation.

What neurological disorders do their products target?

Their products target epilepsy, Parkinson's disease, dystonia, and chronic pain, among others.

How can investors register for the conference?

Investors can register by visiting the conference website for details.

Tags: NMTC Viatris Investor Conferences Healthcare NeuroOne investment conference neurological disorders CFO Ron McClurg
Last updated: Sep 6, 2023